Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-12-17 | Career Highlights: Mr. Doshi is the CEO of Entrada Therapeutics and has led critical functions in biotechnology and pharmaceutical companies including business development, corporate strategy, new product planning. |
Data sourced from SEC filings. Last updated: 2025-10-12